In addition, in the tumour microenvironment, activated CD4+ T cells enhance CD8+ T cell priming, facilitate dendritic cell licensing, and contribute to the formation of tertiary lymphoid structures, thereby amplifying immune surveillance and effector function. Here, CD4 is linked to neoplasm.